Study: NCT00531050

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indacaterol
Description: Single dose of indacaterol 300μg capsule via Concept 1 inhaler device at approximately the same time in the morning (i.e. between 8am and 9am).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose indacaterol matching placebo via Concept 1 device

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Salmeterol
Description: Single dose salmeterol 50μg via the Diskus dry powder inhaler (DPI) in part 1 of the study. Morning single inhalational dose and an evening single inhalation dose of salmeterol 50μg via the Diskus DPI in part 2 of the study.